Trial Profile
A retrospective study to evaluate efficacy and safety of Lenalidomide in patients with relapsed or refractory multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Nov 2015 New trial record